Mizuho raises Ardent Health stock price target to $21 on execution
Mizuho raised its price target on Ardent Health Partners (NYSE:ARDT) to $21 from $13, citing improved execution and higher earnings visibility. The stock is up 103% YTD. Ardent reported Q3 2026 adjusted earnings of $0.31 per share, beating estimates, and raised its adjusted EBITDA guidance to $500M-$535M. The company operates hospitals and healthcare facilities in the U.S.
How this was made
The 30-second read
Why it matters
The upgrade may trigger short covering and new buying, especially after after-hours price jump.
Market read
Analyst target raise provides a fresh catalyst for ARDT, potentially driving short-term price appreciation.
What to watch
Potential regulatory or payer pressure not addressed in the note.
Background
Ardent Health Partners operates hospitals across the US; the price target lift follows Q3 2026 performance and updated EBITDA forecasts.
Ticker impact
Mizuho raised its price target on Ardent Health Partners to $21 from $13, citing improved execution and higher EBITDA guidance.
likely upward pressure as investors price in the higher target.
Target increase of 62% reflects stronger earnings visibility and cost savings, which can attract buying.
Market effects
May lift sentiment for other hospital operators as execution improvements are highlighted.
US healthcare sector could see modest gains.
Limited to US-listed healthcare stocks.
Counterpoint
Target raise could be premature if cost savings are not sustainable.
Key entities
- analystMizuho
Equity research firm raising target.
- companyArdent Health Partners
Hospital operator receiving upgraded target.

